The DOI matches its Crossref record; 40 of the 43 references it cites were found in a registry or an index.
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To quantify the effectiveness of pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance. DATA SOURCES: Medline, Embase, and the Cochrane library searched up to July 2006. Expert opinions sought and reference lists of identified studies and any relevant published reviews checked. STUDY SELECTION: Randomised controlled trials that evaluated interventions to delay or prevent type 2 diabetes in individuals with impaired glucose tolerance. RESULTS: 21 trials met the inclusion criteria, of which 17, with 8084 participants with impaired glucose tolerance, reported results in enough detail for inclusion in the meta-analyses. From the meta-analyses the pooled hazard ratios were 0.51 (95% confidence interval 0.44 to 0.60) for lifestyle interventions v standard advice, 0.70 (0.62 to 0.79) for oral diabetes drugs v control, 0.44 (0.28 to 0.69) for orlistat v control, and 0.32 (0.03 to 3.07) for the herbal remedy jiangtang bushen recipe v standard diabetes advice. These correspond to numbers needed to treat for benefit (NNTB) and harm (NNTH) of 6.4 for lifestyle (95% credible interval, NNTB 5.0 to NNTB 8.4), 10.8 for oral diabetes drugs (NNTB 8.1 to NNTB 15.0), 5.4 for orlistat (NNTB 4.1 to NNTB 7.6), and 4.0 for jiangtang bushen (NNTH 16.9 to NNTB 24.8). CONCLUSIONS: Lifestyle and pharmacological interventions reduce the rate of progression to type 2 diabetes in people with impaired glucose tolerance. Lifestyle interventions seem to be at least as effective as drug treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Our findings that both lifestyle and metformin interventions delayed or prevented diabetes in the DPPOS are consistent with results of other reports of similar interventions with lifestyle or with other antidiabetic drugs.24,25”
From 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (2009) · cites this paper as [25]
In the citing paper
“Sixteen of these systematic reviews included exclusively people with intermediate hyperglycaemia (Aguiar 2014; Gillett 2012; Gillies 2007; Glechner 2015; Gong 2015; Hopper 2011; ICER 2016; Norris 2005; Santaguida 2005; Selph 2015; Stevens 2015; Yamaoka 2005; Yates 2007; Yoon 2013; Yuen 2010; Zheng 2016);”
From Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus (2017) · cites this paper as Gillies 2007
In the citing paper
“In their systematic review, Gillies et al. found that lifestyle and pharmacological interventions reduced the rate of progression to type 2 diabetes in people with IGT and that these interventions seem to be as effective as pharmacological treatment.”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,557
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24 · Cited by 4,519
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Self-citation
Research works printed but not linked: 3
- [4]4. Angelo JB, Huang J, Carden D. Diabetes prevention: a review of current literature. Adv Stud Med 2005;5:250-9.
- [19]19. World Health Organization Expert Committee. Diabetes mellitus, second report. World Health Organ Tech Rep Ser 1980;646:1-80.
- [20]20. WHO Study Group. Diabetes mellitus. World Health Organ Tech Rep Ser 1985;727:1-113.
Cited by
Sorted by citations
Items 801–900 of 1,000
Translating knowledge into action to prevent pediatric and adolescent diabesity: a meeting report
Balakumaran, J., Kao, Y.-Y., Wang, K.-W., Ronen, G. M., MacKillop, J. M., Thabane, L., & Samaan, M. C. (2019) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s209922 · Cited by 5
Burns, R. J. (2019) · Annals of Behavioral Medicine · doi:10.1093/abm/kaz042 · Cited by 5
Versace, V. L., Beks, H., Hannah, W., Namara, K. M., Hague, W. M., Anjana, R. M., Mohan, V., Khunti, K., & Dunbar, J. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1727203 · Cited by 5
Self-citationOsei, E., Zandbergen, A. A. M., Brouwers, P. J. A. M., Mulder, L. J. M. M., Koudstaal, P. J., Lingsma, H. F., Dippel, D. W. J., & den Hertog, H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046113 · Cited by 5
Martínez‐Hervás, S., Morales‐Suárez‐Varela, M., Andrés‐Blasco, I., Lara-Hernández, F., Peraita‐Costa, I., Real, J. T., García-García, A.-B., & Chaves, F. J. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.005 · Cited by 8
Rodriguez, D. V., Lawrence, K. S., Luu, S., Chirn, B., González, J., & Mann, D. (2022) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi54592.2022.00051 · Cited by 5
George, C., Hill, J., Nqebelele, U., Peer, N., & Kengne, A. P. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068672 · Cited by 5
Dwivedi, A., Naqvi, A., Pandey, A., Gupta, V., Malasoni, R., Srivastava, A., Pandey, R. R., Satyanarayana, M., & Pratap, R. (2015) · Pharmacognosy Magazine · doi:10.4103/0973-1296.157689 · Cited by 5
Manuel, D. G., Th, H., Harper, S. B., Anderson, G., Lynch, J. W., & Rosella, L. (2014) · Chronic diseases and injuries in Canada · doi:10.24095/hpcdp.34.2/3.04 · Cited by 5
Primary Prevention of Type 2 Diabetes
Wallace, C. (2012) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721711431926 · Cited by 4
Sarı, H., Esen, B., Yıldırım, S., Pilten, S., & Aydın, H. (2017) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.021444 · Cited by 6
Ahern, A. L., Griffin, S. J., Wheeler, G., Sharp, S. J., Aveyard, P. N., Boyland, E. J., Halford, J. C. G., & Jebb, S. A. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14123 · Cited by 5
Insulin as an Early Treatment for Type 2 Diabetes
Prato, S. D., Bianchi, C., Dardano, A., & Miccoli, R. (2013) · Diabetes Care · doi:10.2337/dcs13-2019 · Cited by 5
How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?
Schwarz, P. E. H., Li, J., Lindström, J., Bergmann, A., Gruhl, U., Saaristo, T., & Tuomilehto, J. O. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0058-7 · Cited by 5
A strategic approach to diabetes prevention: how much evidence is required before we act?
Vita, P., & Colagiuri, S. (2012) · Diabetes Management · doi:10.2217/dmt.12.79 · Cited by 5
Lim, S. S., Takele, W. W., Vesco, K. K., Redman, L. M., ADA PMDI GDM prevention working group, & Josefson, J. L. (2023) · medRxiv · doi:10.1101/2023.04.16.23288650 · Cited by 5
Hernan, A. L., Philpot, B., Janus, E. D., & Dunbar, J. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-510 · Cited by 4
Horikawa, Y., Suzuki, A., Hashimoto, K.-I., Enya, M., Nishida, S., Kobayashi, R., Ohashi, T., Yamazaki, F., Totani, R., Kobayashi, H., et al. (2018) · Diabetology International · doi:10.1007/s13340-018-0379-6 · Cited by 4
Kurian, J., & Mavathur, R. N. (2023) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2023.08.003 · Cited by 6
The Use of Genetic Information in the Prediction of Type 2 Diabetes
Drenos, F. (2015) · Personalized Medicine · doi:10.2217/pme.15.19 · Cited by 4
Treatment of diabetic vasculopathy: an overview
Rahman, S., Majumder, & Rahman (2011) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s17512 · Cited by 4
Ansari, R. M., Dixon, J. B., & Browning, C. J. (2015) · Open Journal of Preventive Medicine · doi:10.4236/ojpm.2015.52006 · Cited by 4
Weir, D. L., Johnson, S. T., Mundt, C., Bray, D., Taylor, L., Eurich, D. T., & Johnson, J. A. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.01.013 · Cited by 4
Turki, Y. M., Hegazy, A. A., & Abaalkhail, B. (2016) · International Journal of Medical Research Professionals · doi:10.21276/ijmrp.2016.2.6.026 · Cited by 4
Computer simulation models of pre-diabetes populations: a systematic review protocol
Leal, J., Khurshid, W., Pagano, E., & Feenstra, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014954 · Cited by 4
Collaborative, O. B. O. T. P.-S., Gray, L. J., Brady, E. M., Albaina, O., Edwardson, C. L., Harrington, D. M., Khunti, K., Miksza, J. K., Raposo, J. F., Smith, E., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0410-3 · Cited by 4
Self-citationGonzález‐Gil, E. M., Giménez-Legarre, N., Cardon, G., Mavrogianni, C., Kivelä, J., Iotova, V., Tankova, T. I., Rurik, I., Liatis, S., Makrilakis, K., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04449-0 · Cited by 5
Teshome, A. A., Zeleke, S., Wolie, A. K., Mengstie, M. A., Muche, Z. T., Nigussie, S., Seid, M. A., Yitbarek, G. Y., Molla, Y. M., Baye, N. D., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01156-7 · Cited by 4
Dallosso, H. M., Khunti, K. K., Gray, L. J., Hulley, K., Ghaly, M., Patel, N., Kai, J., Aujla, N., Davies, M. J., & Yates, T. E. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.05.001 · Cited by 4
Self-citationLei, X., Ishida, E., Yoshino, S., Matsumoto, S., Horiguchi, K., & Yamada, E. (2024) · Nutrients · doi:10.3390/nu16070995 · Cited by 5
Cheng, W. H. G., Dong, W., Tse, E. T. Y., Wong, C. K. H., Chin, W. Y., Bedford, L. E., Fong, D., Ko, W. W., Chao, D. V. K., Tan, K. C. B., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14256 · Cited by 4
Cardiovascular Disease and Diabetes: Two Sides of the Same Coin!
Rahman, S., Majumder, M. A. A., Kabir, R., Haque, M., Gupta, S., Arafat, S. M. Y., Ojeh, N. O., & Dalvi, P. S. (2017) · InTech eBooks · doi:10.5772/intechopen.69038 · Cited by 4
Quality and Outcome Indicators for Prevention of Type 2 Diabetes In Europe −; IMAGE
Pajunen, P., Landgraf, R., Muylle, F., Neumann, A., Lindström, J., Schwarz, P. E. H., & Peltonen, M. (2010) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 4
Is it Time to Seriously Target Obesity to Prevent and Control Diabetes?
Sharma, A. M., Padwal, R. S., Karmali, S., & Birch, D. W. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)52010-6 · Cited by 4
Bailey, C. J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_8 · Cited by 4
Quality indicators for diabetes prevention programs in health care targeted at people at high risk.
Lindström, J., Wikström, K., Maggini, M., Icks, A., Kuske, S., Rothe, U., Sørensen, M., & Zaletel, J. (2015) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_15_03_04 · Cited by 4
Behavior Change Techniques in Apps: Moving Beyond Patient Education to Improve Health Outcomes
Harrington, L. (2020) · AACN Advanced Critical Care · doi:10.4037/aacnacc2020244 · Cited by 4
The insulin resistance syndrome
Sattar, N. A., Welsh, P. I., & Preiss, D. (2015) · doi:10.1002/9781118387658.ch23 · Cited by 4
Efectividad en la prevención de la diabetes tipo 2. Un aterrizaje forzoso en la realidad
Costa, B. (2008) · Medicina Clínica · doi:10.1157/13116576 · Cited by 4
Behavioral Medicine Review: Strategic Management of Diabetes Risk
Terre, L. (2007) · American Journal of Lifestyle Medicine · doi:10.1177/1559827607304320 · Cited by 3
Sugimoto, H., Hironaka, K., Nakamura, T., Yamada, T., Miura, H., Otowa‐Suematsu, N., Fujii, M., Hirota, Y., Sakaguchi, K., Ogawa, W., et al. (2023) · medRxiv · doi:10.1101/2023.09.18.23295711 · Cited by 4
Lifestyle interventions for depression in primary care: a qualitative study
Panjer, J. A., Alma, M., Fokkema, T., Hendriks, T., Cath, D. C., Kik, J., Burger, H., & Berger, M. Y. (2025) · BJGP Open · doi:10.3399/bjgpo.2024.0233 · Cited by 3
Bawazeer, N. M., Alzaben, A. S., Dodge, E., Baker, A. J., Benajiba, N., & Aboul-Enein, B. H. (2025) · Journal of Prevention · doi:10.1007/s10935-025-00835-0 · Cited by 3
George, C., Hill, J., Nqebelele, N. U., Motshwari, D. D., Peer, N., Kengne, A. P., & van Jaarsveld, P. J. (2026) · Scientific Reports · doi:10.1038/s41598-026-36504-3 · Cited by 3
Reza, N. M., & Almadadi, M. (2011) · Cited by 3
Pancreatic Abnormalities at a Young Age in Spontaneously Diabetic Torii (SDT) Rats
Yamada, T., Ohta, T., Shinohara, M., & Yamamoto, T. (2012) · Journal of Animal and Veterinary Advances · doi:10.3923/javaa.2012.1322.1326 · Cited by 3
. Type 2 Diabetes Mellitus in India
Radha, V., Kanthimathi, S., & Mohan, V. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195374759.003.0087 · Cited by 3
Associations between glycaemic deterioration and aortic stiffness and central blood pressure
Johansen, N. B., Rasmussen, S. S., Wiinberg, N., Vistisen, D., Jørgensen, M. E., Pedersen, E. B., Lauritzen, T., Sandbæk, A., & Witte, D. R. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001398 · Cited by 3
Application of Validated HPLC Method for Degradation Study of Vildagliptin and Metformin HCl
Sheikh, I. A., Charde, M. S., & Chakole, R. D. (2017) · International Journal of Advances in Pharmaceutical Analysis · doi:10.7439/ijapa.v7i2.4375 · Cited by 3
Osman, O. A., Saeed, A. A., Mousnad, M. A., & Hamid, A. (2020) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v5i4.438 · Cited by 3
Stability of extemporaneously prepared sitagliptin phosphate solution
Zaid, A. N., Zaaror, Y. A., Kaddumi, A., Ghanem, M. M., Jaradat, N. A., Salah, T. A., Siaj, S., & Omari, L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262068 · Cited by 3
Uchida, T., Kanamori, T., Teramoto, T., Nonaka, Y., Tanaka, H., Nakamura, S., & Murayama, N. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/1026121 · Cited by 3
Aggregation of type-2 diabetes, prediabetes, and metabolic syndrome in German couples
Brieger, L., Schramm, S. H., Schmidt, B., Roggenbuck, U., Erbel, R., Stang, A., & Kowall, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-53417-1 · Cited by 3
Smith, E., Hubbard, S., Freeman, S. C., March, D. S., Wells, M., Saeedi, E., Haddon, L., Khunti, K., & Gray, L. J. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103136 · Cited by 5
Self-citationGray, B. J., Stephens, J. W., Turner, D. G. P., Thomas, M., Williams, S. P., Morgan, K., Williams, M., Rice, S., Bracken, R. M., & on behalf of the Prosiect Sir Gâr Group (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116666476 · Cited by 3
Dietary supplements for prediabetes
Liu, D., Wen, Q., Liu, M., Gao, Y., Luo, L., Zhang, Z., & Chen, Q. (2020) · Medicine · doi:10.1097/md.0000000000020347 · Cited by 3
Schwarz, P. E. H. (2013) · Springer eBooks · doi:10.1007/978-3-642-29908-7_4 · Cited by 3
Prevention of type 2 diabetes - where is the evidence?
Tuomilehto, J. (2014) · Eastern Mediterranean Health Journal · doi:10.26719/2014.20.11.677 · Cited by 3
Prevention of Type 2 Diabetes; from Science to Therapies
Gallagher, E. J., & LeRoith, D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3314-9_1 · Cited by 3
PRAEDIAS - ein Schulungsund Behandlungsprogramm zur Prävention des Typ-2-Diabetes
Gorges, D., Hermanns, N., Haak, T., & Kulzer, B. (2008) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1618631 · Cited by 3
Metformin for people with impaired glucose tolerance or impaired fasting blood glucose
Lü, Q., Ke, L. Q., Tong, N., Cao, L., Wu, T., & Zhang, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008558 · Cited by 3
Waist circumference and impaired fasting glucose screening in a Mediterranean population
Baena-Díez, J. M., Elosúa, R., Cano-Pérez, J. F., Masiá, R., Sala, J., Marrugat, J., & Schröder, H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.08.007 · Cited by 3
Khunti, K. K., Hiles, S., & Davies, M. J. (2008) · Primary Care Cardiovascular Journal (PCCJ) · doi:10.3132/pccj.2008.021 · Cited by 3
Self-citationAujla, N., Stone, M. A., Taub, N. A., Davies, M. J., & Khunti, K. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.08.002 · Cited by 4
Self-citationComplementary and alternative medicine for diabetes mellitus: an overview of systematic reviews
Posadzki, P., Lee, M. S., & Ernst, E. (2012) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2012.01159.x · Cited by 3
Type 2 diabetes risk prediction—Do biomarkers increase detection?
Gray, L. J., & Khunti, K. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.008 · Cited by 3
Self-citationProjecting the impacts of illness on labour force participation: An application of Health&WealthMOD
SCHOFIELD, D. J., Shrestha, R. N., Passey, M. E., Fletcher, S. L., Kelly, S., & Percival, R. (2010) · doi:10.34196/ijm.00059 · Cited by 3
Text messaging to prevent onset of type 2 diabetes.
Free, C. (2013) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(13)70101-3 · Cited by 5
["Advanced trauma life support" in Sweden. A flying start for trauma education].
Rastad, J., & Lindebert, T. (1996) · PubMed · Cited by 3
Behandlung der Adipositas bei Diabetes mellitus
Kulzer, B. (2015) · Springer eBooks · doi:10.1007/978-3-642-54573-3_72 · Cited by 3
Utility of nonblood-based risk assessment for predicting type 2 diabetes mellitus: A meta-analysis
Yoshizawa, S. M., Kodama, S., Fujihara, K., Ishiguro, H., Ishizawa, M., Matsubayashi, Y., Matsunaga, S., Yamada, T., Shimano, H., Kato, K., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.07.026 · Cited by 3
SERUM C-PEPTIDE LEVEL IN OBESE AND NON-OBESE PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mariyam, S. B., Beegum, M. S., & Vasantha, S. C. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/79 · Cited by 4
Vita, P., Reddy, P., Timoshanko, A., Milat, A., Shill, J., Gibson, A. A., Johnson, G., & Colagiuri, S. (2013) · Wiley eBooks · doi:10.1002/9781118661321.ch4 · Cited by 3
Can specific fruits and vegetables prevent diabetes?
Mann, J. I., & Aune, D. (2010) · BMJ · doi:10.1136/bmj.c4395 · Cited by 3
A feasibility study investigating the risk of prediabetes among children in New Zealand
Firestone, R. T., Cheng, S., Corbin, M., Lerwill, N., Pulu, T., Latu, L., Dunn, H., Pulu, V., Firestone, J., Fuge, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-16784-x · Cited by 2
Kumar, P., Pal, Y., Singh, S. D., & Tiwari, S. B. (2025) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_66_24 · Cited by 2
AN OVERALL REVIEW ON OBESITY AND ITS RELATED DISORDERS
Sailaja, A. K. (2015) · Cited by 2
Gul, S., Khatoon, H., Ahmed, N., Rashid, H., & Mirza, A. Z. (2020) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v19i3.45866 · Cited by 2
Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
Schwarz, P. E. H., & Timpel, P. (2016) · Bulletin of the Karaganda University “Biology medicine geography Series” · doi:10.31489/2016bmg4/72-98 · Cited by 2
Xu, Y., Wang, Y., Shi, Y., Yu, M., Xu, W., Wu, Y., Xu, K., Liu, Y., & Xie, L. Y. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13796 · Cited by 2
Prediabetes: what are we talking about?
Escalada, J. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2021-0034 · Cited by 2
Sadiq, A.-A. A., Hanif, S. M., & Muhammad, D. G. (2021) · doi:10.25259/aujmsr_17_2021 · Cited by 2
Sun, C., Lei, Y., Lin, Z., Li, S., Wang, M., & Gu, J. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16384 · Cited by 2
McAuley, E., Fleck, O., Cassidy, L., Kemp, B. J., Cupples, G., Kelly, B. P., Creighton, R. M., Graham, U., Wallace, H. M., Patterson, C. C., et al. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1118509 · Cited by 3
Singla, R. K., Chopra, H., Dubey, A. K., & Shen, B. (2023) · Springer eBooks · doi:10.1007/978-3-030-94753-8_87-1 · Cited by 2
Srividya, N., Haldipur, A. C., & Yerra, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13195-0.00016-8 · Cited by 3
Zhang, L., Liu, J., Cao, Y., Liu, S., Zhao, W., Ci, W., Banzhao, S., Liu, Z., & Liu, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111728 · Cited by 2
A primary care register for impaired glucose handling (IGH): Impact on cardiometabolic profile
Heald, A. H., Knapman, H., Nair, S., Chambers, T., Radford, D., Rushton, T., & Anderson, S. G. (2012) · Primary care diabetes · doi:10.1016/j.pcd.2012.02.002 · Cited by 2
Carter, P., Bodicoat, D. H., Jones, A., Khunti, K. K., Davies, M. J., Edwardson, C. L., Henson, J. J., Yates, T. E., & Coombes, E. G. (2016) · Journal of Public Health · doi:10.1093/pubmed/fdw144 · Cited by 2
Self-citationPrävention, Remission oder Verzögerung der Typ-2-Diabetes-Manifestation – Teil 1
Landgraf, R. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-0872-6365 · Cited by 2
Diet and the Prevention of Type 2 Diabetes
Temple, N. J., & Steyn, N. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-894-8_7 · Cited by 2
Snow, R. J. (2010) · The Journal of the American Osteopathic Association · Cited by 2
Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk
Zhang, G., Zhu, Y., Chen, H., Han, C., Liu, F., Xu, J., & Ye, D. (2015) · Medicine · doi:10.1097/md.0000000000001603 · Cited by 2
Jelinek, G. A., Hadgkiss, E. J., Hassed, C. S., Crimmins, B., Schattner, P. L., Liew, D., Kausman, R., Inder, W. J., Gutbrod, S., & Weiland, T. J. (2012) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2012.24008 · Cited by 2
Interventions that prevent prediabetes from becoming type 2
Morris, D. (2015) · Independent Nurse · doi:10.12968/indn.2015.2.36 · Cited by 2
Kang, J., Sung, S. H., Lee, Y. J., Choi, T., & Choi, S. J. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.10.1353 · Cited by 2
Short term follow-up of prediabetics undergoing elective percutaneous coronary intervention
El‐Hammady, W., Shawky, A., & El-Annany, A. (2013) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2012.12.003 · Cited by 2
Review: exercise plus diet prevents type 2 diabetesCommentary
Carrier, J. (2008) · Evidence-Based Nursing · doi:10.1136/ebn.12.1.11 · Cited by 2
PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE
Magee, L. A., Newstead, J., NG, J., Côté, A., & von Dadelszen, P. (2008) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539508002283 · Cited by 2
Upchurch, S. L. (2007) · Evidence-Based Nursing · doi:10.1136/ebn.10.3.78 · Cited by 2
Metadata
- Authors
- Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K.
- Affiliations
- University of Leicester (GB)
- Corresponding author
- Gillies, Clare L
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2007-01-19
- Volume
- 334
- Issue
- 7588
- Pages
- 299
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC1796695
- OpenAlex
- W2096691922
- Cited by
- 1,171
- References
- 43
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 38 · 2023: 38 · 2022: 40 · 2021: 47 · 2020: 56 · 2019: 56 · 2018: 51 · 2017: 78 · 2016: 74 · 2015: 75 · 2014: 98 · 2013: 97 · 2012: 100
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Medical Research Council
- Economic and Social Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- type 2 diabetes prevention, impaired glucose tolerance, lifestyle intervention, pharmacological interventions, oral antidiabetic drugs, orlistat, diabetes progression, number needed to treat
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Life Style, Randomized Controlled Trials as Topic, Treatment Outcome, Publication Bias, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review